Mary Harne

Mary Harne is currently the Quality Director at AstraZeneca, after serving as a QC Senior Manager from 2013 to 2023. They have a background in managing labs across multiple locations and have significant experience in bioassay, ELISA, and QPCR methods. Prior to AstraZeneca, Mary worked as a Senior Analytical Scientist at GlaxoSmithKline and held various research roles at Human Genome Sciences, contributing to significant improvements in laboratory processes and compliance. Mary earned a Bachelor's degree in Biology from the University of Maryland, completing their studies in 1999.